|
Sam Brill | Ascend, CEO & Director
|
Dr. Dana Lambert, BSc(Pharm), PhD. | Andira, President & CEO
|
Dan Ahrens | HVAC, MSOS, PSIL, VICE, YOLO, Portfolio Manager
|
||
|
|
|
|||
|
Noah Hamman | AdvisorShares, CEO
|
Ron Piccinini | QPX, Portfolio Strategist
|
Loren DeFalco | CB1 Capital, Head of Research
|
||
|
|
|
|
||
|
Joe Saluzzi | Themis Trading, Partner & Co-Founder
|
Margaret Brodie | Rubicon Organics, CEO
|
Eddy Elfenben | CWS, Portfolio Strategist
|
||
|
Minyi Chen | SURE, Portfolio Strategist
|
Christian Anermayer | AtsaiBeckley, Founder
|
|||
|
Todd Harrison | CB1 Capital, CIO & Co-Founder
|
Ian Saunders | Nasdaq Dorsey Wright, Sr. Analyst & Head of Research
|
Eric Offenberger | Vext Science, CEO
|
|
— For Institutional Investor Use Only. Not for Public Distribution —
|
| Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus and summary prospectus, a copy of which may be obtained by visiting the Fund’s website at www.AdvisorShares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor. An investment in the Funds is subject to risk, including the possible loss of principal amount invested. The risks associated with each Fund include the risks associated with the underlying ETFs, which can result in higher volatility, and are detailed in each Fund’s prospectus and on each Fund’s webpage. AIL-890489-2026-02-23 | AIL-DU-946356-2026-06-02 |